Journal article
PPARγ activation in adipocytes is sufficient for systemic insulin sensitization.
- Abstract:
-
Although peroxisome proliferator-activated receptor gamma (PPARγ) agonists such as thiazolidinediones (TZDs) are widely used to treat type 2 diabetes, how its activation in individual tissues contributes to TZD's therapeutic action remains controversial. As TZDs are known to have receptor-independent effects, we sought to establish gain-of-function animal models to delineate the receptor's insulin-sensitizing actions. Unexpectedly, we find that selective activation of PPARγ in adipocytes, but...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Howard Hughes Medical Institute
More from this funder
Helmsley Charitable Trust
More from this funder
Bibliographic Details
- Publisher:
- National Academy of Sciences Publisher's website
- Journal:
- Proceedings of the National Academy of Sciences of the United States of America Journal website
- Volume:
- 106
- Issue:
- 52
- Pages:
- 22504-22509
- Publication date:
- 2009-12-01
- DOI:
- EISSN:
-
1091-6490
- ISSN:
-
0027-8424
- Source identifiers:
-
12716
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:12716
- UUID:
-
uuid:dfbc69c0-26dc-4d9c-96bb-25ff8775a897
- Local pid:
- pubs:12716
- Deposit date:
- 2012-12-19
Terms of use
- Copyright holder:
- Sugii et al
- Copyright date:
- 2009
- Notes:
- Freely available online through the PNAS open access option.
If you are the owner of this record, you can report an update to it here: Report update to this record